PipelinePharma Logo
PipelinePharma Logo

CTD Dossier Marketplace

Direct connection with CTD dossier (IP) owners and manufacturers

Marketing Authorizations Database

Search across marketing authorization registers
Sign in Get started

Generics Products found!

Innovative

Biosimilars

Medical devices

Nutraceuticals

Filters

Nimodipine manufacturers

Filters

None products found

nimodipine

Capsules 30mg

Dossier type
US CTD
Dossier status
Ready to file
Country of origin
United States
GMP approvals
FDA
Manufacturer #16206
This company specializes in a wide range of generic medications, offering both prescription (RX) and over-the-counter (OTC) drugs. Their product portfolio spans various therapeutic areas including antiviral, antibiotic, cough medicine, vitamin supplements, sedatives, antiarrhythmic, and migraine medication. They also produce products for involuntary movement reduction, muscle spasms, sleep aids, pain relief, and allergy treatment. The company manufactures its products in a variety of dosage forms, such as capsules, tablets, suspensions, and oral solutions. Key certifications include GMP compliance, ensuring adherence to high quality and manufacturing standards. While specific product patents aren't mentioned, the focus on generic medications suggests they may leverage existing patents or utilize alternative pathways for product development. Their target markets appear to be widespread, with a potential presence in regions like the EU and North America based on the inclusion of popular brand name equivalents in their product descriptions.

Manufacturer usually replies in 24 days

nimodipine

Capsules 30 mg

Dossier type
US CTD
Dossier status
Ready to file
Country of origin
United States
GMP approvals
FDA
Unavailable markets
United States
Manufacturer #3113
This biopharmaceutical company develops, manufactures, and markets both branded and generic prescription pharmaceuticals. They serve patients globally across regions like the EU and North America. Their product portfolio includes a range of dosage forms and focuses on key therapy areas such as endocrinology (as evidenced by their Cortrophin product). They prioritize quality assurance with GMP certifications and possess patents for some of their products, demonstrating innovation within their field.

Manufacturer usually replies in 49 days

nimodipine

Tablets 30 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Pakistan
GMP approvals
WHO
Manufacturer #17750
This pharmaceutical company boasts a vast portfolio of over 500 products spanning numerous therapeutic areas, including those focusing on prescription medications and over-the-counter drugs. They emphasize stringent quality control measures, adhering to GMP certifications and international regulatory standards. Their research and development department actively works on new drug candidates and improving existing formulations. The company has a global presence with operations in regions like the EU and North America. They offer a range of dosage forms and hold multiple patents for their innovative products.

Manufacturer usually replies in 2 days

Want to see all products?

Subscribe today to benefit from:

  • Streamlined product sourcing - the leading CTD dossiers database focused on finished dosage formulations

  • Direct negotiations - connect and negotiate directly with manufacturers without any brokerage fee

  • Increased profitability - secure the best commercial terms for your business by comparing offers from several manufacturers

Request Subscription
Nimodipine is a medication used to prevent migraines and treat ischemic stroke, and subarachnoid hemorrhage. Manufacturers of nimodipine produce it both as a standalone medication, in combination with citicoline. Nimodipine suppliers market it in the form of oral capsules, oral solutions, and intravenous liquids. The developer and earliest manufacturer of nimodipine is Bayer, who first introduced it into the pharmaceutical market in 1985 under the trade name Nimotop. Currently, the drug is approved in over 60 countries. Other major suppliers of nimodipine globally include Sun Pharmaceuticals, Heritage Pharmaceuticals, Bionpharma, Arbor, Thepharmanetwork, and Sofgen. Nimodipine suppliers and distributors market both generic and trade name formulations of the drug. Buyers are advised that online sellers may attempt to market fraudulent versions of the drug, whereas Pipeline Pharma, through its pre-auditing and quality control procedures ensures that only verified nimodipine manufacturers and wholesalers enter our online marketplace, offering you a risk-free B2B pharmaceutical sales platform. The retail price per 100 (30mg) capsules of trade name nimodipine is approximately 130,00 EUR, whereas the equivalent amount of generic nimodipine tablets costs around 50,00 EUR to 60,00 EUR. A single vial of trade name 10mg/50ml nimodipine injectable solution costs around 20,00 EUR.

Popular Searches

Amoxicillin manufacturers Atorvastatin manufacturers Benzocaine manufacturers Calcium carbonate manufacturers Cloperastine fendizoate manufacturers Gabapentin manufacturers Hyaluronic acid manufacturers Ibuprofen manufacturers Ivermectin manufacturers Levothyroxine manufacturers Lisinopril manufacturers Losartan manufacturers Magnesium manufacturers Melatonin manufacturers Metformin manufacturers Methotrexate manufacturers Metoprolol manufacturers Omeprazole manufacturers Paracetamol manufacturers Prednisone manufacturers Pregabalin manufacturers Semaglutide manufacturers Testosterone enanthate manufacturers Vitamin B12 manufacturers

Willing to unlock more features?

Please fill out form and send us your specific requirements, and we will get back to you as soon as possible

Want unlimited access to the Pipelinepharma database?

Become a subscriber to unlock:

  • Streamlined product sourcing: access the only CTD dossier pipeline and sourcing platform.

  • Direct connections: communicate directly with CTD dossier owners and manufacturers with no brokerage fees.

  • Higher profitability: compare multiple supplier offers and secure the best commercial terms.

  • Expanded network: view supplier portfolios and stay updated on new products.

  • Value-added product ideas: discover products with lower competition potential.

  • Access to marketing authorizations for sale: find already registered products in your target markets.